Clinical Trial Update: Phase I-II Study of Fluorouracil in Combination With Phenylbutyrate in Advanced Colorectal Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II clinical trial evaluating fluorouracil in combination with phenylbutyrate for advanced colorectal cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• FLUOROURACIL (Fluorouracil)
• Phenylbutyrate (phenylbutyrate)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Mucinous Adenocarcinoma of the Colon, Mucinous Adenocarcinoma of the Rectum | Phase 1, Phase 2 | Status: TERMINATED